BRITTNEY GRINER
Brittney Griner: US basketball star freed in a prisoner swap with an arms dealer
The US and Russia have exchanged jailed US basketball star Brittney Griner for notorious arms dealer Viktor Bout, known as the “merchant of death”, held in an American prison for 12 years, reports the BBC.
Griner, who was arrested in the country in February for being in possession of cannabis oil, was sent to a penal colony last month after the Biden administration had previously proposed a prisoner exchange.
“I’m just standing here overwhelmed with emotions,” stated Brittney Griner’s wife Cherelle, who, states the BBC, praised the efforts of the Biden administration in securing Griner’s release.
NORML praised Brittney Griner’s release, noting it should inspire U.S. cannabis law changes
The National Organization for the Reform of Marijuana Laws (NORML) on Thursday praised the release of WNBA player Brittney Griner, writes Newsweek, calling on U.S. lawmakers to use her ordeal as motivation to change domestic cannabis laws.
The Deputy Director of NORML believes the situation illustrates the degree to which cannabis policies and their enforcement are now largely a function of geography.
Erik Altieri, NORML Executive Director, stated: “…it should also cause a serious level of reflection amongst our lawmakers considering that a large number of states still inflict similar penalties for marijuana possession on our own soil, and the current federal policy of marijuana prohibition isn’t notably different than the stance held by [President Vladimir] Putin’s regime in Russia.”
ONTARIO CANNABIS
Ontario cannabis execs concerned the retail scheme is no longer an even playing field
MJ Biz Daily reports that Canadian cannabis producers and brands are increasingly paying Ontario retailers for shelf space and other special treatment for their products, according to industry executives.
Slotting fees are a relatively new phenomenon in cannabis in both the United States and Canada, and this practice is threatening the survival of hundreds of independently owned retailers and craft cultivators. However, as the publication highlights, Ontario regulators prohibit producers and brands from paying retailers for favourable “material” treatment.
Gord Nichol, owner and master grower at North 40 Cannabis, a small cannabis producer in northeastern Saskatchewan, told MJ Biz Daily: “They’re buying up shelf space by sending money to these retailers, which has a double effect. It’s no longer an even playing field for the retailers or producers who don’t want to get involved in these data deals.”
EUROPEAN CANNABIS MARKET
Greencare Capital to move out of the cannabis sector, OCT shares jump & more on MGC Pharma COVID drug
BussinessCann reports on the latest developments in the European cannabis market. The publication reports that Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down.
Additionally, Aquis-listed investment vehicle focused on businesses in CBD, wellness and hemp, Greencare Capital, has announced its plans to move out of the cannabis sector entirely and change its name. The company will now be focusing its investments in areas such as life sciences and crypto.
Finally, BusinessCanna reports that MGC Pharma announced during the week that it had now completed the $1m delivery of its flagship COVID drug Artemic to US distribution partner AMC Holdings.
NORML praised Brittney Griner’s release, noting it should inspire U.S. cannabis law changes
The National Organization for the Reform of Marijuana Laws (NORML) on Thursday praised the release of WNBA player Brittney Griner, writes Newsweek, calling on U.S. lawmakers to use her ordeal as motivation to change domestic cannabis laws.
The Deputy Director of NORML believes the situation illustrates the degree to which cannabis policies and their enforcement are now largely a function of geography.
Erik Altieri, NORML Executive Director, stated: “…it should also cause a serious level of reflection amongst our lawmakers considering that a large number of states still inflict similar penalties for marijuana possession on our own soil, and the current federal policy of marijuana prohibition isn’t notably different than the stance held by [President Vladimir] Putin’s regime in Russia.”
ONTARIO CANNABIS
Ontario cannabis execs concerned the retail scheme is no longer an even playing field
MJ Biz Daily reports that Canadian cannabis producers and brands are increasingly paying Ontario retailers for shelf space and other special treatment for their products, according to industry executives.
Slotting fees are a relatively new phenomenon in cannabis in both the United States and Canada, and this practice is threatening the survival of hundreds of independently owned retailers and craft cultivators. However, as the publication highlights, Ontario regulators prohibit producers and brands from paying retailers for favourable “material” treatment.
Gord Nichol, owner and master grower at North 40 Cannabis, a small cannabis producer in northeastern Saskatchewan, told MJ Biz Daily: “They’re buying up shelf space by sending money to these retailers, which has a double effect. It’s no longer an even playing field for the retailers or producers who don’t want to get involved in these data deals.”
EUROPEAN CANNABIS MARKET
Greencare Capital to move out of the cannabis sector, OCT shares jump & more on MGC Pharma COVID drug
BussinessCann reports on the latest developments in the European cannabis market. The publication reports that Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down.
Additionally, Aquis-listed investment vehicle focused on businesses in CBD, wellness and hemp, Greencare Capital, has announced its plans to move out of the cannabis sector entirely and change its name. The company will now be focusing its investments in areas such as life sciences and crypto.
Finally, BusinessCanna reports that MGC Pharma announced during the week that it had now completed the $1m delivery of its flagship COVID drug Artemic to US distribution partner AMC Holdings.
NORML praised Brittney Griner’s release, noting it should inspire U.S. cannabis law changes
The National Organization for the Reform of Marijuana Laws (NORML) on Thursday praised the release of WNBA player Brittney Griner, writes Newsweek, calling on U.S. lawmakers to use her ordeal as motivation to change domestic cannabis laws.
The Deputy Director of NORML believes the situation illustrates the degree to which cannabis policies and their enforcement are now largely a function of geography.
Erik Altieri, NORML Executive Director, stated: “…it should also cause a serious level of reflection amongst our lawmakers considering that a large number of states still inflict similar penalties for marijuana possession on our own soil, and the current federal policy of marijuana prohibition isn’t notably different than the stance held by [President Vladimir] Putin’s regime in Russia.”
ONTARIO CANNABIS
Ontario cannabis execs concerned the retail scheme is no longer an even playing field
MJ Biz Daily reports that Canadian cannabis producers and brands are increasingly paying Ontario retailers for shelf space and other special treatment for their products, according to industry executives.
Slotting fees are a relatively new phenomenon in cannabis in both the United States and Canada, and this practice is threatening the survival of hundreds of independently owned retailers and craft cultivators. However, as the publication highlights, Ontario regulators prohibit producers and brands from paying retailers for favourable “material” treatment.
Gord Nichol, owner and master grower at North 40 Cannabis, a small cannabis producer in northeastern Saskatchewan, told MJ Biz Daily: “They’re buying up shelf space by sending money to these retailers, which has a double effect. It’s no longer an even playing field for the retailers or producers who don’t want to get involved in these data deals.”
EUROPEAN CANNABIS MARKET
Greencare Capital to move out of the cannabis sector, OCT shares jump & more on MGC Pharma COVID drug
BussinessCann reports on the latest developments in the European cannabis market. The publication reports that Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down.
Additionally, Aquis-listed investment vehicle focused on businesses in CBD, wellness and hemp, Greencare Capital, has announced its plans to move out of the cannabis sector entirely and change its name. The company will now be focusing its investments in areas such as life sciences and crypto.
Finally, BusinessCanna reports that MGC Pharma announced during the week that it had now completed the $1m delivery of its flagship COVID drug Artemic to US distribution partner AMC Holdings.
NORML praised Brittney Griner’s release, noting it should inspire U.S. cannabis law changes
The National Organization for the Reform of Marijuana Laws (NORML) on Thursday praised the release of WNBA player Brittney Griner, writes Newsweek, calling on U.S. lawmakers to use her ordeal as motivation to change domestic cannabis laws.
The Deputy Director of NORML believes the situation illustrates the degree to which cannabis policies and their enforcement are now largely a function of geography.
Erik Altieri, NORML Executive Director, stated: “…it should also cause a serious level of reflection amongst our lawmakers considering that a large number of states still inflict similar penalties for marijuana possession on our own soil, and the current federal policy of marijuana prohibition isn’t notably different than the stance held by [President Vladimir] Putin’s regime in Russia.”
ONTARIO CANNABIS
Ontario cannabis execs concerned the retail scheme is no longer an even playing field
MJ Biz Daily reports that Canadian cannabis producers and brands are increasingly paying Ontario retailers for shelf space and other special treatment for their products, according to industry executives.
Slotting fees are a relatively new phenomenon in cannabis in both the United States and Canada, and this practice is threatening the survival of hundreds of independently owned retailers and craft cultivators. However, as the publication highlights, Ontario regulators prohibit producers and brands from paying retailers for favourable “material” treatment.
Gord Nichol, owner and master grower at North 40 Cannabis, a small cannabis producer in northeastern Saskatchewan, told MJ Biz Daily: “They’re buying up shelf space by sending money to these retailers, which has a double effect. It’s no longer an even playing field for the retailers or producers who don’t want to get involved in these data deals.”
EUROPEAN CANNABIS MARKET
Greencare Capital to move out of the cannabis sector, OCT shares jump & more on MGC Pharma COVID drug
BussinessCann reports on the latest developments in the European cannabis market. The publication reports that Oxford Cannabinoid Technologies (OCT) has seen its share price jump by more than 20% this week after announcing that its CEO Dr John Lucas would be stepping down.
Additionally, Aquis-listed investment vehicle focused on businesses in CBD, wellness and hemp, Greencare Capital, has announced its plans to move out of the cannabis sector entirely and change its name. The company will now be focusing its investments in areas such as life sciences and crypto.
Finally, BusinessCanna reports that MGC Pharma announced during the week that it had now completed the $1m delivery of its flagship COVID drug Artemic to US distribution partner AMC Holdings.
Related Posts
Related Posts
Tilray’s Cannabis Revenues Drop 13% in Q1 as Alcohol Sales Nearly Double
Tilray’s cannabis revenues fell sharply over its first quarter, but its overall revenues were up 13% thanks to a near...
California Cannabis Delivery Giant Eaze Collapses, Marking the Latest High Profile Closure in the State
California’s largest cannabis delivery company, Eaze, is set to close its doors by the end of the year after its...
